Novartis Acquires License To Vaccine That May Prevent Cytomegalovirus

The vaccine could help prevent cytomegalovirus (CMV), a common type of Herpes virus that can cause serious complications in people with weakened immune systems – for instance, AIDS or cancer sufferers, as well as newborns.

Novartis Acquires License To Vaccine That May Prevent Cytomegalovirus

Zdieľať?